Patient info Open main menu

Omeprazole 40 mg Powder for solution for infusion – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
40 mg
Contains active substance:
ATC code:

Patient leaflet - Omeprazole 40 mg powder for solution for infusion

1. WHAT OMEPRAZOLE INFUSION IS AND WHAT IT IS USED FOR

Omeprazole Infusion contains the active substance

omeprazole. It belongs to a group of medicines called

‘proton pump inhibitors’. They work by reducing the

amount of acid that your stomach produces.

Omeprazole Infusion can be used as an alternative to

oral therapy.

2. WHAT YOU NEED TO KNOW BEFORE YOU ARE GIVEN OMEPRAZOLE INFUSION

You must not be given Omeprazole Infusion

  • if you are allergic to omeprazole or any of the other

    ingredients of this medicine (listed in section 6)

  • if you are allergic to other proton pump

    inhibitor medicines (e.g. pantoprazole, lansoprazole,

    rabeprazole, esomeprazole)

  • if you are taking a medicine containing

    nelfinavir (used for HIV infection).

You should not be given Omeprazole infusion if any of

the above apply to you. If you are not sure, talk to your

doctor, nurse or pharmacist before you are given this

medicine.

Warnings and precautions

Omeprazole Infusion may hide the symptoms of other

diseases. Therefore, if any of the following happen to

you before you are given Omeprazole Infusion, or after

you are given it, talk to your doctor straight away.

  • You lose a lot of weight for no reason and have

    problems swallowing

  • You get stomach pain or indigestion
  • You begin to vomit food or blood
  • You pass black stools (blood-stained faeces)
  • You experience severe or persistent diarrhoea, as

    omeprazole has been associated with a small

    increase in infectious diarrhoea

  • You have severe liver problems
  • You are due to have a specific blood test

    (Chromogranin A)

  • You have ever had a skin reaction after treatment

    with a medicine similar to Omeprazole that reduces

    stomach acid.

If you get a rash on your skin, especially in areas

exposed to the sun tell your doctor as soon as you can, as you may need to stop your treatment with

Omeprazole Infusion. Remember to also mention any

other ill-effects like pain in your joints.

Taking a proton pump inhibitor like omeprazole,

especially over a period of more than one year,

may slightly increase your risk of fracture in the hip,

wrist or spine. Tell your doctor if you have

osteoporosis or if you are taking corticosteroids

(which can increase the risk of osteoporosis).

This medicine may affect the way that your body

absorbs vitamin B12, particularly if you need to take it

for a long time. Please contact your doctor if you notice any of the following symptoms, which could indicate

low levels of Vitamin B12:

  • Extreme tiredness or lack of energy
  • Pins and needles
  • Sore or red tongue, mouth ulcers
  • Muscle weakness
  • Disturbed vision
  • Problems with memory, confusion, depression.

    When taking omeprazole, inflammation in your kidney may occur. Signs and symptoms may include decreased volume of urine or blood in your urine and/or hypersensitivity reactions such as fever, rash, and joint stiffness. You should report such signs to the treating physician.

    Children and adolescents

    This medicine should not be given to children and adolescents under 18 years of age. There is limited experience with omeprazole for intravenous use in children.

    Other medicines and Omeprazole Infusion

    Tell your doctor, nurse or pharmacist if you are taking, have recently taken or might take any other medicines, including medicines obtained without a prescription. This is because Omeprazole Infusion can affect the way some medicines work and some medicines can have an effect on Omeprazole Infusion.

    You must not be given Omeprazole Infusion if you are taking a medicine containing nelfinavir (used to treat HIV infection).

    Tell your doctor, nurse or pharmacist if you are taking any of the following medicines:

    • Ketoconazole, itraconazole, posaconazole or voriconazole (used to treat infections caused by a fungus)
    • Digoxin (used to treat heart problems)
    • Diazepam (used to treat anxiety, relax muscles or in epilepsy)
    • Phenytoin (used in epilepsy). If you are taking phenytoin, your doctor will need to monitor you when you start or stop taking Omeprazole Infusion • Medicines that are used to thin your blood, such as warfarin or other vitamin K blockers. Your doctor may need to monitor you when you start or stop taking Omeprazole Infusion
    • Rifampicin (used to treat tuberculosis)
    • Atazanavir (used to treat HIV infection)
    • Tacrolimus (in cases of organ transplantation) • St John’s wort (Hypericum perforatum) (used to treat mild depression)
    • Cilostazol (used to treat intermittent claudication) • Saquinavir (used to treat HIV infection)
    • Clopidogrel (used to prevent blood clots (thrombi)) • Erlotinib (used to treat cancer)
    • Methotrexate (a chemotherapy medicine used in high doses to treat cancer) – if you are taking a high dose of methotrexate, your doctor may temporarily stop your Omeprazole Infusion treatment.

If your doctor has prescribed the antibiotics amoxicillin and clarithromycin as well as Omeprazole Infusion to treat ulcers caused by Helicobacter pylori infection, it is very important that you tell your doctor about any other medicines you are taking.

Pregnancy, breast-feeding and fertility

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, nurse or pharmacist for advice before you are given this medicine.

Omeprazole is excreted in breast milk but it is not likely to influence the child when therapeutic doses are used. Your doctor will decide whether you can take Omeprazole Infusion if you are breastfeeding.

Driving and using machines

Omeprazole Infusion is not likely to affect your ability to drive or use any tools or machines. Side effects such as dizziness and visual disturbances may occur (see section 4). If affected, you should not drive or operate machinery.

Omeprazole Infusion contains sodium

This medicine contains less than 1mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’. What is in this leaflet

  1. 1.

    What Omeprazole Infusion is and what it is

    used for

  2. 2.

    What you need to know before you are given

    Omeprazole Infusion

  3. 3. How Omeprazole Infusion is given to you
  4. 4. Possible side effects
  5. 5. How to store Omeprazole Infusion
  6. 6. Contents of the pack and other information

The entire contents of each vial should be dissolved in approximately 5 ml and then immediately diluted to 100 ml. Sodium chloride 9 mg/ml (0.9%) solution for infusion or glucose 50 mg/ml (5%) solution for infusion must be used. The stability of omeprazole is influenced by the pH of the solution for infusion, which is why no other solvent or quantities should be used for dilution.

Preparation

  1. 1.

    With a syringe, draw 5 ml of infusion solution from

    the 100 ml infusion bottle or bag

  2. 2.

    Add this volume to the vial with the freeze-dried

    omeprazole, mix thoroughly making sure all

    omeprazole is dissolved

    1. 3. Draw the omeprazole solution back into the syringe 4. Transfer the solution into the infusion bag or bottle 5. Repeat steps 1-4 to make sure all omeprazole is transferred from the vial into the infusion bag or bottle.

INFORMATION FOR THE HEALTHCARE PROFESSIONAL The following information is intended for medical or healthcare professionals only:

Alternative preparation for infusions in flexible containers

  1. 1. Use a double-ended transfer needle and attach to the injection membrane of the infusion bag. Connect the other needle-end from the vial with freeze-dried omeprazole
  2. 2. Dissolve the omeprazole substance by pumping the infusion solution back and forward between the infusion bag and the vial
  3. 3.

    Make sure all omeprazole is dissolved.

    The solution for infusion is to be administered in an intravenous infusion for 20-30 minutes.

    Dosage

    40 mg once daily is recommended. In patients with Zollinger-Ellison Syndrome, 60 mg once daily is the recommended starting dose. Doses exceeding 60 mg daily should be divided and given twice daily.

    Hepatic impairment: A daily dose of 10-20 mg may be sufficient.

3. HOW OMEPRAZOLE INFUSION IS GIVEN TO YOU

Omeprazole Infusion can be given to adults including the elderly. There is limited experience with Omeprazole Infusion for intravenous use in children.

Being given Omeprazole Infusion

  • Omeprazole Infusion will be given to you by a doctor who will decide how much you need
  • The medicine will be given to you as an infusion into one of your veins

If you are given more Omeprazole Infusion than you should

If you think you have been given too much Omeprazole Infusion, talk to your doctor straight away.

If you have any further questions on the use of this medicine, ask your doctor, nurse or pharmacist.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

If you notice any of the following rare but serious side effects, stop using Omeprazole Infusion and contact a doctor immediately.

  • Sudden wheezing, swelling of your lips, tongue and throat or body, rash, fainting or difficulties in swallowing (severe allergic reaction)
  • Reddening of the skin with blisters or peeling. There may also be severe blisters and bleeding in the lips, eyes, mouth, nose and genitals. This could be ‘Stevens-Johnson syndrome’ or ‘toxic epidermal necrolysis’
  • Yellow skin, dark urine and tiredness which can be symptoms of liver problems.

Other side effects include:

Common side effects (may affect up to 1 in 10 people)

Uncommon side effects (may affect up to 1 in 100 people)

Rare side effects (may affect up to 1 in 1,000 people)

Very rare side effects(may affect up to 1 in 10,000 people)

Side effects with unknown frequency (frequency cannot be estimated from the available data) • Inflammation of the gut which causes diarrhoea. • Rash, possibly with pain in the joints

  • If you are on Omeprazole Infusion for more than three months it is possible that the levels of magnesium in your blood may fall. Low levels of magnesium can be seen as fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness or increased heart rate. If you get any of these symptoms, please tell your doctor promptly. Low levels of magnesium can also lead to a reduction in potassium or calcium levels in the blood. Your doctor may decide to perform regular blood tests to monitor your levels of magnesium.

Irreversible visual impairment has been reported in isolated cases of critically ill patients who have received omeprazole intravenous injection, especially at high doses, but no causal relationship has been established.

Omeprazole infusion may in very rare cases affect the white blood cells leading to immune deficiency. If you have an infection with symptoms such as fever with a severely reduced general condition or fever with symptoms of a local infection such as pain in the neck, throat or mouth or difficulties in urinating, you must consult your doctor as soon as possible so that a lack of white blood cells (agranulocytosis) can be ruled out by a blood test. It is important for you to give information about your medicine at this time.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE OMEPRAZOLE INFUSION

Keep this medicine out of the sight and reach of children.

Do not use Omeprazole Infusion after the expiry date which is stated on the vial and carton after EXP. The expiry date refers to the last day of that month. This medicinal product does not require any special temperature storage conditions. Keep the vial in the outer container.

Shelf life after reconstitution: 12 hours after reconstitution with 0.9% sodium chloride solution and 6 hours after reconstitution with 5% glucose solution. From a microbiological point of view, the product should be used immediately unless it has been reconstituted under controlled and validated aseptic conditions.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Omeprazole Infusion contains

  • The active substance is omeprazole. Each vial of powder contains omeprazole sodium equivalent to 40 mg of omeprazole
  • The other ingredients are disodium edetate and sodium hydroxide.

What Omeprazole Infusion looks like and contents of the pack

Omeprazole 40 mg powder for solution for infusion comes in a vial.

The dry powder in the vial is made into a solution before it is given to you.

Pack sizes: 5 vials.

Marketing Authorisation Holder

Ibigen Srl. Via Fossignano, 2, 04011 Aprilia (LT), Italy

Manufacturer

Sofarimex Industria Química e Farmaceutica Lda, Agualva-2735-213, Cacém, Portugal

This leaflet was last revised in 08/2026

•Swelling of the feet and

ankles

•Disturbed sleep

(insomnia)

•Spinning feeling

(vertigo)

•Changes in blood tests

that check how the liver

is working

•Dizziness, tingling

feelings such as “pins and needles”, feeling sleepy

•Skin rash, lumpy rash (hives) and itchy skin •Generally feeling unwell and lacking energy.

•Changes in blood count

including agranulocytosis

(lack of white blood cells)

•Muscle weakness

•Enlarged breasts in men. •Effects on your stomach

or gut: diarrhoea,

stomach pain,

constipation, wind

(flatulence)

•Headache

•Feeling sick (nausea) or being sick (vomiting) •Benign polyps in the stomach.

•Blood problems such as a

reduced number of white

cells or platelets. This can

cause weakness, bruising

or make infections more

likely

•Allergic reactions,

sometimes very severe,

including swelling of the

lips, tongue and throat,

fever, wheezing

•Low levels of sodium in

the blood. This may cause

weakness, being sick

(vomiting) and cramps

•Feeling agitated,

confused or depressed

•Taste changes

•Eyesight problems such

as blurred vision

•Suddenly feeling wheezy

or short of breath

(bronchospasm)

•Dry mouth

•An inflammation of the inside of the mouth •An infection called

“thrush” which can affect the gut and is caused by a fungus

•Hair loss (alopecia) •Skin rash on exposure to sunshine

•Liver problems, including jaundice which can cause yellow skin, dark urine, and tiredness

•Joint pains (arthralgia) or muscle pains (myalgia) •Severe kidney problems (interstitial nephritis) •Increased sweating.

•Aggression

•Seeing, feeling or

hearing things that are

not there (hallucinations)

•Severe liver problems

leading to liver failure

and inflammation of the

brain

•Sudden onset of a severe rash or blistering or peeling skin. This may be associated with a high fever and joint pains (Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis)

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 31745/0026

Last revision stated in the text: August 2026 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Omeprazole 40 mg powder for solution for infusion

Prescription needed? Yes, prescription-only medicine (POM)
Active substance Omeprazole
Strength 40 mg
Pharmaceutical form Powder for solution for infusion
Vial containing white to off-white sterile powder.
How is it taken Intravenous
Excipients Disodium edetate dihydrate, Sodium hydroxide
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Shelf life Unopened pack: 3 years
Reconstituted solution:
Chemical and physical in-use stability has been demonstrated for 12 hours at 25°C after reconstitution with sodium chloride 9mg/ml (0.9%) solution for infusion and for 6 hours at 25°C after reconstitution with glucose 50mg/ml (5%) solution for infusion.
From a microbiological point of view, the product should be used immediately. If not used immediately, in-use storage times and conditions are the responsibility of the user and would normally be no longer than 24 hours at 2-8°C unless reconstitution has taken place in controlled and validated aseptic conditions.
Storage Keep the vial in the outer container.
This medicinal product does not require any special temperature storage conditions.
Drug group (ATC) Proton pump inhibitors
  1. A Alimentary tract and metabolism drugs
    1. A02 Drugs for acid related disorders
      1. A02B Drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
        1. A02BC Proton pump inhibitors for peptic ulcer and GORD
          1. A02BC01 omeprazole
Marketing authorisation PL 31745/0026 (first authorised 4 December 2024)
Marketing authorisation holder Ibigen Srl
Codes BNF 01030500

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.2.0 of 19 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.